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Distinct signals and immune cells drive liver pathology
and glomerulonephritis in ABIN1[D485N] mice
Sambit Kumar Nanda1,* , Tsvetana Petrova1,2,*, Francesco Marchesi3 , Marek Gierlinski4, Momchil Razsolkov2,
Katherine L Lee5 , Stephen W Wright5, Vikram R Rao6, Philip Cohen1 , J Simon C Arthur2
We report that TLR7, IL-6, and the adaptive immune system are
essential for autoimmunity and glomerulonephritis but not for
liver pathology in mice expressing the ubiquitin-binding–defective
ABIN1[D485N] mutant. The blood and organs of ABIN1[D485N] mice
have exceptionally high numbers of patrolling monocytes (pMo),
which develop independently of IL-6 and the adaptive immune
system. They are detectable in the blood months before autoim-
munity and organ pathology are seen and may have diagnostic
potential. The splenic pMo, inflammatory monocytes (iMo), and
neutrophils of ABIN1[D485N] mice expressed high levels of mRNAs
encoding proteins released during NETosis, which together with
the high numbers ofmonocyte-derived dendritic cells (MoDCs)may
drive the liver pathology in ABIN1[D485N] mice, and contribute to
the pathology of other organs. The splenic iMo of ABIN1[D485N]
mice displayed high expression of mRNAs encoding proteins con-
trolling cell division andwere actively dividing; thismay underlie the
increased pMo and MoDC numbers, which are derived from iMo. An
orally active IRAK4 inhibitor suppressed all facets of the disease
phenotype and prevented the increase in pMo numbers.
DOI 10.26508/lsa.201900533 | Received 23 August 2019 | Revised 24 October
2019 | Accepted 24 October 2019 | Published online 6 November 2019
Introduction
Systemic lupus erythematosus (SLE, lupus) is a complex disease in
which the body’s immune system attacks its own organs, resulting in
severe inflammation and damage of these tissues. Up to 70% of lupus
patients develop nephritis, which is caused by immunoglobulins and
complement components becoming deposited in the glomerulus of
the kidney. For this reason, studies aimed at gaining a molecular
understanding of the causes of lupus have mainly focused on the
pathways leading to glomerulonephritis. However, lupus affects many
other organs. For example, the liver is an important target of SLE
(Bessone et al, 2014), whereas 50% of lupus patients experience lung
problems, most frequently pleuritis and pneumonitis. Antinuclear
antibodies (ANAs) and double-stranded DNA (dsDNA) antibodies have
been detected in the pleural fluid (Porcel et al, 2007; Toworakul et al,
2011), but whether they contribute to the lung pathology seen in lupus
or are just a consequence of the disease is unclear.
Genome-wide association studies have identified polymorphisms
in a number of human genes that predispose to SLE. These include
polymorphisms in TNIP1, the gene encoding A20-binding inhibitor of
NF-κB1 (ABIN1), which has been reported to predispose to SLE inmany
human populations (Gateva et al, 2009; Han et al, 2009; Nair et al, 2009;
Adrianto et al, 2012; Gregersen et al, 2012; Shi et al, 2014). A key role of
ABIN1 in immune cells is to restrict activation of the protein kinases
termed TAK1 (TGFβ-activated protein kinase 1) and IKKβ (IκB kinase β),
preventing the overproduction of inflammatory mediators by myeloid
and B cells. ABIN1 exerts this effect by interacting with the ubiquitin
chains that activate TAK1 and IKKβ (reviewed (Cohen and Strickson,
2017)), as revealed by genetic studies with knock-in mice in which
ABIN1 was mutated to a ubiquitin-binding–defective mutant. Stimu-
lation of the dendritic cells or B cells from these ABIN1[D485N] mice
with ligands that activate TLRs or nucleotide-binding oligomerization
domain–containing receptor 2 induced the hyperactivation of TAK1
and IKKβ, causing a several-fold increase in the secretion of TNF, IL-6,
and IL-12 (Nanda et al, 2011).
The ABIN1[D485N] mice are born at Mendelian frequencies and
develop normally, but at 3 mo of age, develop enlarged spleens and
lymph nodes with greatly increased numbers of T-follicular helper
(Tfh) cells and germinal centre B (GCB) cells. At 4 mo, high levels of
many immunoglobulins (Igs) appear in the serum, including ANAs
and antibodies to dsDNA, followed by severe inflammation of the
kidney, liver, and lungs after 5–6 mo (Nanda et al, 2011). In contrast,
most ABIN1 KO mice die during embryonic development; however,
the few that survive to adulthood develop a phenotype similar to
but evenmore aggressive than ABIN1[D485N] mice (Zhou et al, 2011).
The autoimmunity and organ inflammation displayed by ABIN1
[D485N] mice is abolished by crossing to mice that do not express
myeloid differentiation primary response 88 (MyD88) (Nanda et al,
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2011), an adaptor protein required for signaling by interleukin 1 (IL-1)
family members and ligands that activate TLRs. MyD88 forms oligo-
meric complexes with members of the IL-1 receptor-associated ki-
nases (IRAKs), termed the Myddosome, and lupus in ABIN1[D485N]
mice is also prevented by crossing to mice in which IRAK4 or IRAK1 are
replaced by kinase-inactive mutants. These studies demonstrate that
components of the Myddosome are key drivers of autoimmunity in
thismodel. In contrast, crossing tomice inwhich IRAK2 is replaced by a
functionally inactive mutant has no effect on the progression of the
disease (Pauls et al, 2013; Nanda et al, 2016).
Many human patients with lupus display high levels of IFN-
stimulated genes in their peripheral blood mononuclear cells.
Flt3-derived plasmacytoid dendritic cells from ABIN1[D485N] mice
overproduce IFNα and IFNβ upon stimulation with ligands that activate
TLR7 or TLR9, but autoimmunity is unaffected by crossing to mice that
lack the type 1 IFN-associated receptor 1 subunit (IFNAR1), which is
essential for type I IFN signaling. Moreover, the kidney pathology is only
improved modestly in ABIN1[D485N] × IFNAR1 KO mice. The over-
production of type 1 IFNs, therefore, seems to be a consequence and not
a cause of the phenotype of ABIN1[D485N] mice (Nanda et al, 2016).
Because polymorphisms in TNIP1 predispose to human lupus and
ABIN1[D485N] mice develop spontaneously a disease that closely
resembles some types of human SLE (Caster et al, 2013), we have
continued to investigate the molecular mechanisms driving lupus in
this model. Here, we demonstrate that the MyD88-IRAK4-IRAK1 sig-
naling axis drives both the autoimmune and autoinflammatory as-
pects of the lupus phenotype, as well as the increased numbers of
patrolling and inflammatory monocytes and the striking changes to
their gene expression profiles seen in this model.
Results
Autoantibody production and glomerulonephritis requires IL-6 in
ABIN1[D485N] mice, but liver pathology and lung inflammation do
not
IL-6 is known to stimulate the generation of splenic GCB cells (Kopf
et al, 1998), which are required for isotype switching somatic
hypermutation, leading to the production of high-affinity anti-
bodies such as ANAs and anti-dsDNA autoantibodies. Both den-
dritic cells and B cells from ABIN1[D485N] mice show enhanced IL-6
production relative to cells from wild-type (WT) mice after stimu-
lation with TLR-activating ligands (Nanda et al, 2011). To investigate
the contribution of IL-6 to the lupus phenotype, we crossed ABIN1
[D485N] mice to IL-6 KO mice and found that splenomegaly was
reduced (Fig 1A) and the formation of GCB cells abolished (Figs 1B
and S1A). Consistent with these observations, the levels of dsDNA
antibodies, as well as the total IgM, IgG, and IgE, in the serum were
reduced in ABIN1[D485N] × IL-6 KO mice relative to the ABIN1[D485N]
mice (Figs 1C–E), and glomerulonephritis was strongly suppressed
(Figs 1F, and S1B). However, neither the liver pathology (Figs 1G and
S1C) nor lung inflammation (Figs 1H and S1D) were affected. Taken
together, these experiments suggest that the overproduction of IL-6
in ABIN1[D485N] mice contributes to germinal centre formation,
antibody production, and glomerulonephritis, but is not required
for the liver pathology or lung inflammation seen in this model.
The adaptive immune system is required for the development of
glomerulonephritis, but not for the liver pathology of ABIN1
[D485N] mice
The results presented in Fig 1 suggested that the formation of GCB
cells and increased production of autoantibodies might be the
triggers for glomerulonephritis. To further investigate this pos-
sibility, we crossed ABIN1[D485N] mice to RAG2 KO mice (Shinkai
et al, 1992), which lack mature B and T cells and, therefore, cannot
develop GCB cells or autoantibodies. We found that glomeru-
lonephritis measured at 6 mo of age was completely suppressed
in ABIN1[D485N] × RAG2 KO mice (Figs 2A, and S2A and B). Lung
inflammation was also greatly reduced, but not abolished, by
crossing to RAG2 KO mice (S2C and S2C), indicating an important
contribution of the adaptive immune system to the lung pa-
thology. In contrast, the liver pathology was unaffected (S2D
and S2D), indicating that it occurs independently of adaptive
immunity.
The observations in ABIN1[D485N] × RAG2 KO mice suggested that
the liver pathology was being driven by innate immune and/or non-
immune cells. To distinguish between these possibilities, we gener-
ated bone marrow chimaeric mice by injecting equal proportions of
wild-type (WT) and ABIN1[D485N] bonemarrow cells into irradiatedWT
mice (Fig 2D). Themixed chimaericmice developed liver pathology and
splenomegaly 4 mo after the reconstitution (Figs 2E and F and S2E),
which, together with the data from the cross to RAG2 KO mice, in-
dicated an important role for haematopoietic non-T, non-B cell(s) in
these processes.
As bone marrow transfer generates B and T cells, the chimaeric
mice also developed aspects of the disease that are dependent on
the adaptive immune system such as GCB cell formation (Figs 2G
and S2F), increased ANA and anti-dsDNA antibodies (Figs 2H and I)
and glomerulonephritis (Figs 2J and S2G).
TLR7 is required for autoimmunity and glomerulonephritis in
ABIN1[D485N] mice, but liver pathology and lung inflammation
are less dependent on TLR7
BXSB/Yaa mice in which the TLR7 gene is duplicated develop an
autoimmune disease similar to ABIN1[D485N] mice (Pisitkun et al,
2006; Santiago-Raber et al, 2009b) and the spontaneous develop-
ment of lupus in several other lupus-prone mouse lines is attenu-
ated by crossing to TLR7 KOmice (Christensen et al, 2006; Demaria et
al, 2010; Santiago-Raber et al, 2010). We found that crossing the ABIN1
[D485N] mice to TLR7 KO mice prevented splenomegaly (Fig 3A), as
well as the increase in splenic Tfh cells (Figs 3B and S3A) and GCB cells
(Figs 3C and S3B). Consequently, ABIN1[D485N] × TLR7 KOmice did not
display increased levels of dsDNA antibodies (Fig 3D) or Igs (Figs 3E
and F), and glomerulonephritis was also strongly suppressed (Figs 3G
and S3C). In contrast, the liver pathology was reduced, but not
abolished (Figs 3H and S3D), and the decrease in lung inflammation
was not statistically significant (Figs 3I and S3E). Taken together, the
results presented in Figs 1–3 indicate that autoimmunity and
autoinflammation in ABIN1[D485N] mice arise from different inputs
and outputs that feed into and out of the central core MyD88-IRAK4-
IRAK1 signaling axis.
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Figure 1. Autoimmunity in ABIN1[D485N] mice, but not liver or lung inflammation, is prevented by crossing to IL-6 KO mice.
(A) Spleen weights (left hand panel) of 26-wk-old WT (n = 6), ABIN1[D485N] (n = 4), IL-6 KO (n = 5), and ABIN1[D485N] × IL-6 KO (n = 6) mice. (B) GCB cell numbers in spleens
of 17-wk-old WT (n = 5), ABIN1[D485N] (n = 5), IL-6 KO (n = 8), and ABIN1[D485N] × IL-6 KO (n = 6) mice. (C) Anti-dsDNA antibodies in the serum of 26-wk-old mice. (D, E) Same
as (C), except that IgM, IgG1, and IgG2b, IgG2a and IgE concentrations were measured. (F, G, H) Same as (C), except that kidney (F), liver (G), and lung (H) pathology scores
fromWT, ABIN1[D485N], IL-6 KO, and ABIN1[D485N] × IL-6 KOmice (n = 4–6) were determined. (A, B, C, F, G, H) Each symbol shows the data from a single mouse. Statistical
significance between the genotypes was calculated using one-way ANOVA and the Tukeys post-hoc test (A, B, C, D, G) or the Kruskal-Wallis and the Mann-Whitney tests (E,
F, H);* denotes P < 0.05, ** P < 0.01 and *** denotes P < 0.001.
Source data are available for this figure.
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Figure 2. Glomerulonephritis but not liver pathology is independent of the adaptive immune system in ABIN1[D485N] mice and requires one or more myeloid cell
types.
(A, B, C) glomerulonephritis (A), lung inflammation (B), and liver pathology (C) from 24 to 26-wk-old WT, ABIN1[D485N], RAG2 KO, and ABIN1[D485N] × RAG2 KO mice (4–6
mice of each genotype). (D) Schematic showing how the bone marrow chimaera was generated. (E, F, G, H, I, J) show Liver pathology score (E), spleen weights (F), splenic
GCB cells (B220+ve CD95+veGL-7+ve) as a % of the total B220+ve B cells (G), ANA (H) and anti-dsDNA antibodies (I), and glomerulonephritis scores (J) from control andmixed
chimaeric mice (5–7 mice of each experimental group). (A, B, C, E, F, G, H, I, J) Each symbol shows the data from a single mouse. Significance of the difference between the
two groups was calculated using the unpaired t test with Welch’s correction (E, F, I, J), or the Mann–Whitney test (A, B, C, G); * denotes P < 0.05, ** denotes P < 0.01, and
*** denotes P < 0.001.
Source data are available for this figure.
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Increased numbers of patrolling and inflammatory monocytes in
the blood and organs of ABIN1[D485N] mice
To identify which myeloid cells might contribute to the disease
phenotype of ABIN1[D485N] mice, we characterised the myeloid cell
populations in different tissues (Figs 4 and 5). These studies revealed
greatly increased numbers of patrollingmonocytes (pMo) in the blood
of ABIN1[D485N] mice (CD11b+veCD115+veLy6C−veCX3CR1+veMHCII−ve), and
modestly increased numbers of inflammatory monocytes (iMo, de-
fined as CD11b+veCD115+veLy6C+veCX3CR1+ve) (Figs 4A and B) (Geissmann
et al, 2003; Auffray et al, 2007). There were also increased numbers
of both pMo and iMo in the spleen (Fig 4C), where an alternative
Figure 3. Differences in autoimmunity, glomerulonephritis, liver, and lung pathology in ABIN1[D485N] × TLR7 KO mice.
(A) Spleen weights of 17-wk-old WT mice (n = 6), ABIN1[D485N] mice (n = 5), TLR7 KO mice (n = 7), and ABIN1[D485N] × TLR7 KO (n = 10) mice. (B, C) Numbers of Tfh (B) and
GCB (C) cells in the spleens of 17-wk-old WT (n = 7), ABIN1[D485N] (n = 5), TLR7 KO (n = 4), and ABIN1[D485N] × TLR7 KO mice (n = 8). (D, E, F) Concentrations of different
antibodies in the serum of 26-wk-old WT (n = 6), ABIN1[D485N] (n = 6), TLR7 KO (n = 8), and ABIN1[D485N] × TLR7 KOmice (n = 11). (E, F) The error bars in (E) and (F) are shown ±
SEM. (G, H, I) Kidney (G), liver (H), and lung (I) pathology scores fromWT, ABIN1[D485N], TLR7 KO, and ABIN1[D485N] × TLR7 KOmice (4–8mice of each genotype). (A, B, C, D,
G, H, I) Each symbol represents a biological replicate from one mouse. In A, B, E-IgG1 and F-IgG2a the significance between genotypes was calculated using one-way
ANOVA and Tukey’s post hoc test; significance in (C, D, E-IgM and IgG2b, G, H, I) was calculated using the Kruskal–Wallis nonparametric multiple comparison and the
Mann–Whitney test; * denotes P < 0.05, ** denotes P < 0.01, and *** denotes P < 0.001.
Source data are available for this figure.
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Figure 4. Characterisation of the monocyte
populations in the blood and spleen of ABIN1
[D485N] mice.
(A) The cells were gated based on Forward Scatter - Area
(FSC-A) and Side Scatter - Area (SSC-A) followed by
exclusion of doublets and dead cells. (B, C) Flow
cytometry characterization of monocytes in the blood
(B) and spleen (C) of 22-wk-old mice. Patrolling
monocytes (pMo) in the blood were characterised as
CD115+veCD11b+veLy6C−veCX3CR1+veMHCII−ve and inflammatory
monocytes (iMo) as CD115+veCD11b+veLy6C+veCX3CR1+ve.
Splenic pMo were identified as CD45+veGr-1−ve/low
NK1.1−veCD11b+veLy6C+veCX3CR1+veMHCII−ve and splenic iMo
as CD45+veGr-1−ve/lowNK1.1−veCD11b+veLy6C+veCX3CR1+ve.
(D, F) pMo (D) and iMo (F) are shown as a % of the live
leukocytes in the blood of WT mice (white bars; n = 6–10)
and ABIN1[D485N] mice (grey bars; n = 6–8). (E, G)
Same as (D) and (F), except that the total numbers of
pMo and iMo in the spleen were measured. The error
bars show ± SEM. (D, E, F, G) Significance between the
genotypes at each time points was calculated using
the unpaired t test with Welch’s correction in (D, F)
or the Mann–Whitney test (E, G); *denotes P < 0.05,
** denotes P < 0.01, and *** denotes P < 0.001.
Source data are available for this figure.
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gating strategy was necessary since the stability, and hence
staining of CD115 is reduced when these organs are processed
(Breslin et al, 2013). The pMo in spleen were defined as CD45+veGr-
1−ve/low NK1.1−veCD11b+veLy6C−veCX3CR1+veMHCII−ve and the iMo as
CD45+veGr-1−ve/lowNK1.1−veCD11b+ve Ly6C+ve CX3CR1+ve (Fig 4C) (Jung
et al, 2000).
Remarkably, increased numbers of pMo in the blood and spleen
were already detectable when the ABIN1[D485N] mice were only
4 wk old, 8 wk before the onset of splenomegaly and increase in ANA
(Figs 4 and S4) and 12 wk before glomerulonephritis, liver pathology,
or lung inflammation became detectable (Nanda et al, 2011; Caster
et al, 2013). The increase in pMo numbers became even more striking
Figure 5. Characterisation of the monocyte populations in the kidney, liver, and lungs of ABIN1[D485N] mice.
(A, B, C) Same as (C) in Fig 4, except that the pMo and iMo in the kidney (A), liver (B), and lungs (C) were analysed. (D, E)Numbers of pMo (D) and iMo (E) in the kidney, liver,
and lungs of 20–22-wk-old WT mice (white bars; n = 6) and ABIN1[D485N] mice (grey bars; n = 6). The error bars show ± SEM. (D, E) Significance between the genotypes was
calculated using the unpaired t test with Welch’s correction in (D) (liver) and (E) (liver and kidney) or the Mann–Whitney test in (D) (kidney and lung) and (E) (lung);
* denotes P < 0.05 and ** denotes P < 0.01.
Source data are available for this figure.
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as the mice aged, the blood pMo population reaching 29 and 33% of
the total number of live leukocytes after 16 and 22 wk of age, re-
spectively (Fig 4D). The number of pMo in the spleen also increased
strikingly as the mice aged (Fig 4E), whereas increases in iMo in the
blood (Fig 4F) and spleen (Fig 4G) weremoremodest. There was also a
striking increase in the pMo and iMo present in the kidney, liver, and
lungs of the ABIN1[D485N] mice (Figs 5A–E).
Infiltration of different immune cells into the organs of ABIN1
[D485N] mice
In view of the remarkable increase in patrolling monocytes in ABIN1
[D485N] mice, we also examined the infiltration of other immune cells
into the kidney, liver, and lungs of 20-wk-old mice (Figs S5 and S6). We
observed increased numbers of neutrophils in the livers of ABIN1
[D485N] mice compared with WT mice, but decreased numbers of
neutrophils in the kidney and lungs (Fig S5A), and the potential
significance of these observations is discussed later. There were also
marked increases in the number of monocyte-derived dendritic cells
(MoDCs) in the liver and lungs, but not in the kidney (Fig S5B). The
eosinophil numbers in the kidneys, liver, and lungs (Fig S5C) and NK
cell numbers in the kidneys and lungs (Fig S5D) were decreased in
ABIN1[D485N] mice, whereas macrophage numbers in the three or-
gans did not differ significantly in WT and ABIN1[D485N] mice (Fig S5E).
The total number of CD4+ and CD8+ T cells was increased in the
kidney and liver, but not in the lungs (Figs S6A and B), but the
percentage of activated (CD44+ve) T cells was higher in all three
organs in ABIN1[D485N] mice (Figs S6C and D). Finally, B cell
numbers in the kidney and lungs of WT and ABIN1[D485N]mice were
similar, but increased in the liver of ABIN1[D485N] mice (Fig S6E).
The MyD88-IRAK4-IRAK1 signaling axis drives the increase in
patrolling and inflammatory monocytes in ABIN1[D485N] mice by
an IL-6–independent mechanism that does not require the
adaptive immune system
To investigate which signaling components were responsible for
increasing the number of pMo and iMo, we crossed the ABIN1
[D485N] mice to TLR7 KO mice and MyD88 KO mice and to mice
expressing kinase-inactive mutants of IRAK4 (IRAK4[D329A]) or
IRAK1 (IRAK1[D359A]). Each cross strongly suppressed the numbers
of pMo and iMo in the blood and spleen, apart from the cross to
TLR7 KO mice, where the decrease in iMo numbers in the blood was
modest (Figs 6A–D). In contrast, the pMo and iMo numbers were not
affected, or only affected slightly, by crossing ABIN1[D485N] mice to
RAG2 KO or IL-6 KO mice, respectively (Figs 6E–L). The increased
numbers of pMo and iMo in ABIN1[D485N] mice are, therefore,
driven by the same MyD88-IRAK4-IRAK1 signaling pathway that
drives lupus but, similar to the liver pathology, the increases in
these monocytes are unaffected by the absence of IL-6 or an
adaptive immune system.
The gene expression profiles of splenic pMo, iMo, and neutrophils
are strikingly different in ABIN1[D485N] and WT mice
To characterize the pMo and iMo in greater detail, we performed
RNA sequencing on the purified splenic monocytes. The gene
expression profiles of the pMo and iMo from ABIN1[D485N] and WT
mice show many similarities, but also marked differences (Figs 7A
and B, and S7A and B). The up-regulated mRNAs in ABIN1[D485N]
monocytes included that encoding myeloperoxidase (MPO) and,
consistent with this finding, the MPO protein was also up-regulated
(Figs S7C and D, and S8A). MPO catalyses the formation of hypo-
chlorous acid (Hampton et al, 1998), a potent bactericidal non-
radical oxidant. The RNAs encoding the proteinases elastase
(elane), proteinase 3 (prtn3), cathepsin G (ctsg), and cathelicidin
(camp) were also up-regulated in pMo and iMo from ABIN1[D485N]
mice. These mRNAs, as well as those encoding MPO, the TLR4 li-
gands S100a8 and S100a9, and lactotransferrin (ltf), are also up-
regulated in splenic neutrophils from ABIN1[D485N] mice (Figs 7C
and S8A–H, and Table S1). The potential significance of these
findings is discussed later.
Principal component analysis showed that the gene transcrip-
tion profiles of the splenic iMo from ABIN1[D485N] mice differed
markedly from WT iMo and from both WT and ABIN1[D485N] pMo. A
major difference was the high level of mRNAs encoding proteins
required for cell division in ABIN1[D485N] iMo (Fig 7D and Table S2).
Consistent with these findings, cell cycle analysis of the splenic iMo
revealed that, in contrast to WT iMo, many ABIN1[D485N] iMo were in
the S and G2 phases of the cell division cycle (Figs 7E and F). This
may account for increased iMo numbers and the even larger in-
crease in the pMo numbers in ABIN1[D485N] mice, because the pMo
are derived from iMo (see the Discussion section).
All facets of the disease phenotype of ABIN1[D485N] mice are
reduced by an orally active IRAK4 inhibitor
Our earlier studies had shown that autoimmunity and glomeru-
lonephritis in ABIN1[D485N] mice were prevented by crossing to
MyD88 KO mice (Nanda et al, 2011) or mice expressing kinase-
inactive mutants of IRAK4 or IRAK1 (Nanda et al, 2016). These ob-
servations and the critical role of the MyD88-IRAK4-IRAK1 signaling
axis in all aspects of the disease phenotype led us to study the
effects of PF 06426779, an orally active IRAK4-specific inhibitor (Lee
et al, 2017) (Fig S9A). The inclusion of this compound in the food of
adult WT mice (4g/kg food) caused the level of PF06426779 in the
serum to oscillate over the 12 h/12 h light/dark cycle, peaking at 6
μM in the dark cycle when themice were feeding and declining to 1.5
μM during the light cycle, when they were not.
The compoundwas given to ABIN1[D485N]mice for 10 wk, starting
at 6–8 wk of age. At this age, increased numbers of pMo and iMo
were already present, but splenomegaly, auto-immunity, and organ
pathology were not (Nanda et al, 2011). We found that PF 06426779
prevented further increases in pMo numbers in the blood (Fig 8A),
as well as splenomegaly (Fig 8B) and the formation of splenic GCB
cells (Fig 8C). The IRAK4 inhibitor also reduced the concentration of
anti-dsDNA (Fig 8D) and attenuated glomerulonephritis (Figs 8E and
S9B). Importantly, the IRAK4 inhibitor also reduced liver in-
flammation (Figs 8F and S9C), and there was a statistically signif-
icant decrease in lung inflammation (Figs 8G and S9D). In contrast,
the pMo in the blood of control ABIN1[D485N] mice not given the
IRAK4 inhibitor continued to increase, and these mice developed
splenomegaly, auto-antibodies, glomerulonephritis, liver pathol-
ogy, and lung inflammation (Figs 8A–G).
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An IRAK4 inhibitor reduces cytokine secretion by monocytes
The stimulation of splenic pMo and iMo from ABIN1[D485N] mice
with R837, a ligand for TLR7, induced the secretion of TNF and the
chemokines CCL3 and CCL4 (Figs 8H–M). The iMo additionally se-
creted IL-6 and IL-12p40 (Figs 8N and O). The IRAK4 inhibitor
PF0642779 reduced R837-stimulated cytokine secretion from pMo
and iMo (Figs 8H–O), indicating that IRAK4 catalytic activity not only
drives the increase in pMo numbers in ABIN1[D485N] mice but also
the secretion of cytokines by these cells. The stimulation of iMo with
LPS induced the secretion of IL-6, CCL5, CXCL1, and G-CSF, which was
also suppressed by PF06426779 (Figs 8 and S9E).
Discussion
Studies aimed at gaining a molecular understanding of the path-
ogenetic mechanisms underlying lupus have focused mainly on
autoimmunity and how it triggers glomerulonephritis in this dis-
ease. Here, we also examined the liver pathology and lung in-
flammation in ABIN1[D485N] mice, where lupus arises spontaneously
from a point mutation that disables the ubiquitin-binding function of
a negative regulator of TLR-MyD88-IRAK4-IRAK1 signaling. We found
that the expression of IL-6 in ABIN1[D485N] mice was needed for the
development of autoimmunity culminating in glomerulonephritis, but
had no effect on liver pathology or lung inflammation (Fig 1). Moreover,
in contrast to glomerulonephritis, the development of the liver pa-
thology did not require the adaptive immune system (Fig 2) and in-
stead was driven by non-B, non-T cells. These observations indicate
that the disease phenotype arises from a combination of autoim-
munity and auto-inflammation.
Autoimmunity in ABIN1[D485N] mice is clearly dependent on one
or more endogenous TLR7-activating ligands (Fig 3), presumably an
RNA(s) released during cell death and/or produced by commensal
microbiota. The latter possibility implies that the identity of the li-
gand(s) may vary with the composition of the microbiome and could,
therefore, vary with the facility in which the mice are housed. Re-
cently, another laboratory reported that crossing ABIN1 KO mice to
either TLR7 KOmice or TLR9 KOmice had little effect on autoimmunity
or glomerulonephritis and that crossing to TLR7/TLR9 double KOmice
was required to prevent these hallmarks of lupus (Kuriakose et al,
2019). This is unexpected because the disease phenotype of other
lupus-prone mouse strains is prevented by crossing to TLR7 KOmice,
whereas crossing to TLR9 KO mice has actually been reported to
exacerbate lupus by causing the up-regulation of TLR7 (Christensen
et al, 2006; Nickerson et al, 2010; Stoehr et al, 2011). Other differences
in the mechanisms that negatively regulate TLR7 and TLR9 signaling
have recently been identified (Majer et al, 2019). The difference
between the findings of Kuriakose et al and those reported here
might be explained by the distinct microbiomes of thesemice and/or
by the loss of additional functions of the ABIN1 protein in the ABIN1
KO mice. Only the ubiquitin-binding function of the protein is dis-
abled in ABIN1[D485N]mice, but the interaction of ABIN1with A20 (the
product of the tnfaip3 gene) and other, as yet unidentified, functions
of ABIN1 will also be lost in ABIN1 KO mice. The loss of additional
functionsmight also explainwhy ABIN1 KOmice start dyingwhen they
are only 4 wk old. Indeed, 50% of the ABIN1 KO mice had died after 8
wk, before glomerulonephritis was detectable (Kuriakose et al, 2019),
suggesting that the early death is unrelated to glomerulonephritis. In
contrast, ABIN1[D485N] mice only start dying when severe multiorgan
damage has developed at 6 mo of age (Nanda et al, 2011). The partial
alleviation of liver pathology and lack of a significant reduction in
lung inflammation in ABIN1[D485N] × TLR7 KO mice suggests the
involvement of an additional TLR(s) and its endogenous ligand(s) in
the development of liver and lung pathology. The ABIN1 KOmice also
display liver and lung inflammation (Zhou et al, 2011), but quantitative
scoring and the effect of crossing to TLR7 KO and/or TLR9 KOmice on
these disease endpoints was not reported (Kuriakose et al, 2019).
An inference from our results is that anti-IL-6 antibodies or TLR7
antagonistsmay be ineffective, or only partially effective, in preventing
lupus, and the failure of an anti-IL-6 monoclonal antibody to achieve
its primary end goals in a phase 2 clinical trial for lupus (Wallace et al,
2017) is consistent with this notion. These considerations suggest
that only drugs targeting a core component of the MyD88-IRAK4-
IRAK1 pathway (Fig 9) will have the potential to suppress all facets
of the lupus phenotype and led us to treat the ABIN1[D485N] mice
with an orally active IRAK4 inhibitor. The results demonstrated
that the IRAK4 inhibitor did indeed reduce both the autoimmune
and autoinflammatory aspects of the disease (Fig 8).
A different IRAK4 inhibitor (BMS-986126) has been shown to
reduce the level of anti-dsDNA in the serum and to suppress kidney
pathology in two other lupus-prone mouse lines (Murphy Roths
Large/ lymphoproliferation (MRL/lpr) and New Zealand Black/
White (NZB/W) mice) (Dudhgaonkar et al, 2017), but its efficacy in
alleviating the pathology and inflammation of other organs was not
reported. Lupus in MRL/lpr mice seems to be caused by a mutation
in the CD95 receptor that prevents the removal of autoreactive T
and B cells, whereas the mutation(s) causing lupus in NZB/W mice
is (are) unknown. However, autoimmunity and kidney pathology
were both attenuated by crossing MRL/lpr mice to TLR7 KO mice
(Christensen et al, 2006) or delayed by the administration of TLR7
antagonists to NZB/W mice (Dong et al, 2005). These observations,
together with the efficacy of an IRAK4 inhibitor in reducing auto-
immunity imply that TLR7-MyD88-IRAK4-IRAK1 signaling is up-
regulated in MRL/lpr and NZB/W mice, but the mechanism(s)
causing hyperactivation in these mouse strains is (are) unclear.
Figure 6. The pMo and iMo in the blood and spleen of different mouse lines.
(A, B, C, D, E, F, G, H, I, J, K, L) ABIN1[D485N] mice were crossed to TLR7 KO, MyD88 KO, IRAK4[D329A], or IRAK1[D359A] mice (A, B, C, D), RAG2 KO mice (E, F, G, H) or IL-6 KO
mice (I, J, K, L). (A, B, C, D, E, F, G, H, I, J, K, L) The pMo in the blood (A, E, I), and spleen (B, G, K) and iMo in the blood (C, F, J) and spleen (D, H, L) were measured in 17-wk-old
mice with the indicated genotypes. The numbers of mice analysed are denoted by n and each symbol represents an individual mouse. Statistical significance between the
genotypes is shown by the horizontal bars and asterisks and was calculated using one-way ANOVA and the Tukeys post hoc test (A, B, C, H, I, J, K, L) or the Kruskal–Wallis
and the Mann–Whitney tests (D, E, F, G); * denotes P < 0.05, **P < 0.01, and *** denotes P < 0.001. No horizontal bars are shown for data sets that have not reached statistical
significance.
Source data are available for this figure.
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Polymorphisms in four genes encoding proteins that control the
MyD88-IRAK4-IRAK1 pathway (Fig 9) have been reported to pre-
dispose to SLE and other autoimmune diseases in many human
populations, namely, TLR7 (Shen et al, 2010; Tian et al, 2012; Lee et al,
2016), IRAK1 (Jacob et al, 2007, 2009; Kaufman et al, 2013), TNIP1
(Gateva et al, 2009; Han et al, 2009; Nair et al, 2009; Adrianto et al,
2012; Gregersen et al, 2012; Shi et al, 2014), and TNFAIP3 (Musone
et al, 2008; Bates et al, 2009; Adrianto et al, 2011). These observations
suggest that hyperactivation of the MyD88-IRAK4-IRAK1 pathway
contributes to disease progression in a significant proportion of
human lupus patients. Lupus is far more prevalent in women than
men (Tedeschi et al, 2013) and it is, therefore, of interest that the
TLR7 and IRAK1 genes are X-linked in both humans and mice.
Importantly, TLR7 escapes X-chromosome inactivation in human
immune cells, and the TLR7 protein is expressed in themyeloid cells
of women at twice the level present in men (Souyris et al, 2018). This
may contribute to the prevalence of lupus in women; recall that
duplication of the tlr7 gene in mice causes lupus to develop spon-
taneously (Pisitkun et al, 2006).
The two types of monocytes present in mice have been termed
inflammatory (iMo) and patrolling (pMo), the former giving rise to
the latter. The iMo also give rise to macrophages and monocyte-
derived dendritic cells (reviewed Ginhoux & Jung (2014)). Previous
studies reported high levels of monocytes in at least two lupus-prone
Figure 7. RNA-seq of splenic monocytes and neutrophils in ABIN1[D485N] mice.
(A, B, C) MA (M - log ratio and A - mean average) plots showing differential expression of selected genes in pMo (A), iMo (B), and neutrophils (C) obtained by RNA-seq
analysis of cells purified from the spleens of 20–22-wk-old WT (n = 4) and ABIN1[D485N] mice (n = 4). Significantly up-regulated or down-regulated genes are shown in
yellow. The Y-axis shows log2 fold change and X-axis shows log2 of normalized gene expression (counts per million [cpm]) in the ABIN1[D485N] cells. (D) As in B, except that
up-regulated genes involved in regulating cell division in ABIN1[D485N] iMo are shown. (E, F) Representative flow cytometry plots (E) and bar graph (F) showing cell cycle
analysis of iMo in the spleens of 14-w-oldWT (n = 4) and ABIN1[D485N] (n = 3) mice. (F) Statistical significance between the genotypes was calculated using two-way ANOVA
and the Sidak post hoc test (F); *** denotes P < 0.001.
Source data are available for this figure.
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mouse strains (Wofsy et al, 1984; Santiago-Raber et al, 2009a), whereas
high levels of nonclassical monocytes, thought to be equivalent to
pMo in mice, were reported in human lupus patients (Cros et al, 2010;
Kuriakose et al, 2019). Here, we studied each type of monocyte
individually and found particularly high levels of pMo in the blood,
spleen, and other organs of ABIN1[D485N] mice (Figs 4 and 5). High
levels of pMo in the blood and kidneys of ABIN1 KO mice were also
reported recently (Kuriakose et al, 2019). Here, we made the novel and
potentially important finding that the number of pMo in the blood of
ABIN1[D485N]mice are already increased considerably months before
autoimmunity or organ pathology became detectable (Figs 4D and E).
If this is also the situation in humans, then the measurement of pMo
numbers in the bloodmight be a useful diagnostic indication of those
at risk of developing lupus, such as the siblings of lupus patients or
humans with polymorphisms in genes known to predispose to lupus,
allowing early intervention with IRAK4 and/or IRAK1 inhibitors to
prevent the onset of the disease.
Mice with a conditional deletion of ABIN1 in myeloid cells were
recently reported to develop autoantibodies and glomerulone-
phritis, indicating an essential role for myeloid cells in driving
autoimmunity in ABIN1 KO mice (Kuriakose et al, 2019). These ob-
servations can be rationalized with our findings (Fig 1) if it ismyeloid
cells that produce the IL-6 needed to drive autoimmunity and
glomerulonephritis. The iMo from ABIN1[D485N] mice secreted IL-6
in response to TLR ligands (Fig 8O) and could be one source of the
IL-6. The splenic pMo did not secrete IL-6 in response to these
stimuli, but chemokines secreted by pMo may recruit other IL-6–
secreting cells to the organs that they infiltrate. The conventional
dendritic cells and B cells of ABIN1[D485N] mice also overproduce
IL-6 when stimulated with TLR-activating ligands (Nanda et al, 2011).
Glomerulonephritis in ABIN1[D485N] × RAG2 KO mice was un-
detectable up to 6 mo of age, indicating that a functional adaptive
immune system is required for this phenotype to develop. The pMo
numbers in the blood and spleen of ABIN1[D485N] × RAG2 KO mice
were similar to those present in ABIN1[D485N] mice (Figs 6E and G),
indicating that the pMo numbers in ABIN1[D485N] mice increase
independently of the adaptive immune system.
There was also a striking increase in the infiltration of pMo into
the kidneys, liver, and lungs of ABIN1[D485N] mice (Figs 5D and E),
suggesting that pMo may contribute to the pathology observed in
these organs. Further evidence that pMo contribute to the kidney
pathology is suggested by the recent finding that chimaeric mice
devoid of pMo, which were generated by injecting liver cells from
the foetus of ABIN1 KO × Nr4a1 KO mice into irradiated WT mice, did
not develop glomerulonephritis (Kuriakose et al, 2019). Surprisingly,
and in contrast to our findings in ABIN1[D485N] × RAG2 KO mice, the
ABIN1 KO × RAG1 KO mice, which also lack T and B cells, still de-
veloped glomerulonephritis (Kuriakose et al, 2019). The reason for
this difference with our results is unclear, although it might be
related to the more severe phenotype of ABIN1 KO mice.
Crossing the ABIN1[D485N] mice to RAG2 KO mice not only abol-
ished glomerulonephritis but also lung inflammation, indicating that
the pathology of both of these organs requires the adaptive immune
system. Consistent with these findings, there were increased numbers
of T cells in the kidneys of ABIN1[D485N] mice and an increased
proportion of activated T cells in both the kidneys and lungs (Fig S6). In
contrast, despite increased numbers of T and B cells and a higher
proportion of activated T cells in the liver, the liver pathology was
unaffected in the ABIN1[D485N] × RAG2 KO mice. Thus, the liver pa-
thology is driven by non-B, non-T cells, raising the question of which
haematopoietic cells are responsible for the liver pathology.
Interestingly, we observed that the infiltration of neutrophils into
the liver was increased in ABIN1[D485N] mice, whereas less neu-
trophils were present in the kidneys and lungs of ABIN1[D485N]
mice than inWTmice (Fig S5A). An important function of neutrophils
is their ability to undergo NETosis (neutrophil extracellular trap
formation), a form of cell death that generates local high con-
centrations of antimicrobial compounds to kill pathogens extra-
cellularly (Urban et al, 2009; Papayannopoulos et al, 2010; Aratani,
2018). Interestingly, increased NETosis has been linked to SLE
(Hakkim et al, 2010) and MPO and proteinases released during
NETosis cause tissue damage (Knight et al, 2012; Metzler et al, 2014;
Bjornsdottir et al, 2015). It is, therefore, of great interest that the
splenic neutrophils in ABIN1[D485N] mice expressed much higher
levels of RNAs encoding proteins released during NETosis, sug-
gesting that increased NETosis may be a factor driving the liver
pathology. Moreover, RNA-seq analysis unexpectedly revealed that
the pMo and iMo in ABIN1[D485N] mice also express high levels of
RNAs encoding proteins important for NETosis (Fig 7 and Table S1).
The numbers of pMo and iMo are greatly elevated in the livers of
ABIN1[D485N] mice, and monocytes have been reported to undergo
NETosis (Granger et al, 2017). Therefore, NETosis driven by neu-
trophils, pMo and iMo may all contribute to the liver pathology
displayed by ABIN1[D485N] mice. However, there was also a striking
increase in the number of monocyte-derived dendritic cells in the
livers of ABIN1[D485N] mice (Fig S5). Therefore, increased pro-
duction of molecules by MoDCs that can cause tissue damage, such
as cytokines, may be another factor contributing to the liver pa-
thology. The increased number of MoDCs could also contribute to
T-cell activation and hence to the kidney and lung pathology.
Figure 8. The IRAK4 inhibitor PF 06426779 prevents autoimmunity and organ inflammation in ABIN1[D485N] mice.
ABIN1[D485N] mice (6–8 wk old) or age-matchedWTmice were fed for 10 wk on R&M3 diet without or with PF 06426779 (PF) (4 g/kg). (A) At the times indicated, pMo in the
blood was quantitated. The WT mice and ABIN1[D485N] mice fed on normal R&M3 diet are shown by the white and dark grey bars, respectively, whereas the ABIN1[D485N]
mice fed on R&M3 diet containing PF are shown by the light grey bars. (B, C) Spleen weights (B) and splenic GCB cells (B220+ve CD95+veGL-7+ve) (C) were measured 10 wk after
feeding WT (black squares) or ABIN1[D485N] mice (open symbols) with R&M3 diet without (−) or with (+) PF. (D, E, F, G) As in (C), except that anti-dsDNA antibodies in the
serum (D), glomerulonephritis (E), liver pathology (F), and lung inflammation (G) were measured. (B, C, D, E, F, G) Each symbol represents data from a single mouse. (H, I, J,
K, L, M, N, O) splenic pMo (5 × 104 cells) (H, I, J) and splenic iMo (5 × 104 cells) (K, L, M, N, O) from ABIN1[D485N] mice (n = 5) were incubated for 1 h with the indicated
concentrations of PF, then stimulated for 6 h with 1.0 μg/ml R837. (H, I, J, K, L, M, N, O) TNF (H, K), CCL3 (I, L), CCL4 (J, M), IL-12p40 (N), and IL-6 (O) concentrations in the
culture medium were then measured. The error bars show ± SEM. (A, B, C, D, E, F, G, H, I, J, K, L, M, N, O) Statistical significance between the experimental groups
was calculated using the one-way ANOVA and the Tukey’s post hoc test in (A, H, I, J, K, L, M, O) or the Kruskal–Wallis and the Mann–Whitney tests in (B, C, D, E, F, G, O);
* denotes P < 0.05, **P < 0.01, and *** denotes P < 0.001.
Source data are available for this figure.
Mechanism of lupus in ABIN1[D485N] mice Nanda et al. https://doi.org/10.26508/lsa.201900533 vol 2 | no 6 | e201900533 13 of 19
Interestingly, and similar to our observations, a population of
low-density gradient neutrophils present in human lupus patients
had enhanced expression of the genes encodingMPO, elastase, and
cathelicidin compared with neutrophils from healthy controls and
had a higher capacity to produce NETs and, hence, tissue damage
(Villanueva et al, 2011; Carmona-Rivera et al, 2015).
Our genetic analysis established that hyperactivation of MyD88-
IRAK4-IRAK1 signaling drives the increased numbers of pMo and iMo
in ABIN1[D485N] mice (Fig 6) and, consequently, an IRAK4 inhibitor
arrested the increase in pMo and iMo numbers in ABIN1[D485N]
mice (Fig 8). The RNA-seq analysis of splenic iMo from ABIN1[D485N]
mice revealed that they express far higher levels of mRNAs encoding
proteins required for cell division thanWT iMo (Fig 7D). Consistent with
this finding, the splenic iMo from ABIN1[D485N] mice, but not WTmice,
were found to be actively engaged in cell division (Figs 7E and F).
Because iMo give rise to pMo (Yona et al, 2013), this finding can
potentially explain the increased numbers of pMo in the blood (Fig 4D)
and organs (Figs 4E, and 5D and E) of ABIN1[D485N]mice, as well as the
increased numbers of iMo. Understanding how MyD88-IRAK4-IRAK1
signaling stimulates the transcription of genes controlling the cell
division cycle in monocytes and the conversion of iMo to pMo will be
interesting topics for future research.
Materials and Methods
Generation and maintenance of mouse lines
The ABIN1[D485N], ABIN1[D485N] × MyD88 KO, ABIN1[D485N] × IRAK4
[D329A], and ABIN1[D485N] × IRAK1[D359A] knock-in mice were
generated as described (Nanda et al, 2011, 2016). The ABIN1[D485N]
mice, back-crossed to C57Bl6/J mice (Charles River Laboratories)
more than 15 generations, were crossed to TLR7 KO mice on a
C57Bl6/J background (Jackson Laboratories). This C57Bl6/J strain is
free of the DOCK2 mutation present in C57Bl mice from Harlan
Laboratories, which affects the immune system (Mahajan et al,
2016). The C57Bl6/J CD45.1 mouse line was obtained from Charles
River. Mice were provided with free access to food (R&M3 pelleted
irradiated or autoclaved diet) and water. Animals were kept in
individually ventilated cages at 21°C, 45–65% relative humidity and
a 12 h/12 h light/dark cycle under specific-pathogen–free condi-
tions in accordance with UK and European Union regulations.
Experiments on mice were approved by the University of Dundee
Ethical Review Committee under a UK Home Office project license.
Isolation of cells and flow cytometry
The antibodies used for flow cytometry analysis and their sources
are summarised in Table S3. Single-cell suspensions were made
from the spleen and lungs (Nanda et al, 2011; Moro et al, 2015). The
kidneys were cut into 1–2-mm segments and digested for 45 min at
37°C in 7 ml Roswell Park Memorial Institute (RPMI) supplemented
with 50 μg/ml Liberase (Roche) and 10 μg/ml DNase I (Roche).
Tissues were then further processed as described (Liao et al, 2017).
For phenotypic analysis of the blood, 2–3 drops of blood were
collected from mouse tails in ice-cold RPMI buffer containing 10%
foetal bovine serum, 10% red blood cell lysis buffer (Sigma-Aldrich)
and 2 mM EDTA or via cardiac puncture in MiniCollect EDTA tubes
(Greiner Bio-One). Erythrocytes were eliminated by treatment for
2 min at 21°C with red blood cell lysis buffer. Cell suspensions were
Figure 9. Pathways to autoimmunity and autoinflammation in ABIN1[D485N]
mice.
The MyD88-IRAK4-IRAK1 signaling pathway induces the formation of hybrid
ubiquitin chains containing both Lys63 (K63)-linked and Met1 (M1)-linked
ubiquitin (Ub) chains. ABIN1 and its binding partner A20 interact with these
ubiquitin chains, restricting the activation of TAK1 and IKKβ. The ABIN1[D485N]
mutation prevents interaction with ubiquitin chains causing hyperactivation of
TAK1 and IKKβ and the overproduction of inflammatory mediators. The
overproduction of IL-6 drives the formation of GCB cells, autoantibodies, and
glomerulonephritis, but not the autoinflammatory aspects of the disease
phenotype, which include the liver pathology. The liver pathology is driven by
one or more myeloid cells independently of the adaptive immune system. The
MyD88-IRAK4-IRAK1 signaling axis also drives increased formation of atypical
patrolling and inflammatory monocytes (pMo, iMo) in ABIN1[D485N] mice which
may contribute to the liver pathology, as well as IL-6 production and
glomerulonephritis. The activation of TLR7 drives autoimmunity in ABIN1[D485N]
mice, but additional TLRs contribute to other aspects of the disease phenotype.
The IRAK4 inhibitor, PF06426779, suppresses both the autoimmune and
autoinflammatory aspects of the disease phenotype of ABIN1[D485N] mice.
Polymorphisms in TLR7, IRAK1, ABIN1, and A20 predispose to human lupus. The
genes encoding TLR7 and IRAK1 are X-linked and may account, at least in part, for
the prevalence of lupus in women.
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stained with 0.5 μg/ml DAPI (BioLegend), acquired on a BD FACSVerse
using BD FACSuite software (BD Bioscience) and total cell numbers
calculated using FlowJo software (Tree Star, Inc.). For flow cytometry
analysis, the cells were blocked for 20 min at 4°C with FcR antibody
(purified anti-CD16/32; BD Pharmigen) diluted (1:50) in PBS containing
1% Bovine serum albumin. For detection of surface antigens, the cells
were stained for 20 min at 4°C with the appropriate fluorophore-
conjugated antibodies. To exclude dead cells, 0.5 μg/ml DAPI was
added before analysis. To characterise MPO expression, splenic cells
were first stained for surface marker expression and then fixed and
permeabilized using Intracellular Fixation & Permeabilization Buffer
Set according to themanufacturer’s instructions. After permeabilization,
the cells were stained for 1 h at 4°C with anti-MPO antibody (Abcam)
and analysed. Data were collected using BD FACSCanto or BD
LSRFortessa II and BD FACSDiva software (BD Bioscience) and the
results analysed by FlowJo software. Doublets were excluded by
gating for Forward Scatter-Area (FSC-A) and Forward Scatter-Width
(FSC-W), whereas DAPI−ve cells were gated for further analysis to
exclude dead cells.
Cell cycle analysis
Splenocytes were stained for surface expression of CD11b and Ly6C,
then washed, fixed for 30min at 4°C in ice cold 70% ethanol, washed
twice with PBS, and incubated for 5 min with RNase A (100 μg/ml)
(Thermo Fisher Scientific). Propidium iodide (Sigma-Aldrich) was
added to a final concentration of 50 μg/ml. Data were acquired
using BD LSRFortessa II and analysed by FlowJo software.
Cell sorting and cell stimulation
Splenocytes from ABIN1[D485N] mice were incubated FcR antibody
as described earlier. The cells were then incubated for 20 min with
anti-CD3, anti-CD19, anti-NK1.1, anti-Ly6G, and anti-Ter119 biotinylated
antibodies. T, B, NK cells, neutrophils, and erythrocytes were de-
pleted using Streptavidin MicroBeads and LD Columns (Miltenyi)
according to Miltenyi’s instruction. The cells from the flow-
through were stained as described earlier. Patrolling monocytes
(DAPI−veCD45+veCD11b+veNK1.1−veMHCII−veLy6C−veCX3CR1+ve) and inflamma-
torymonocytes (DAPI−veCD45+veCD11b+veNK1.1−veMHCII−veLy6ChighCX3CR1+ve)
were sorted on an Influx cell sorter (BD Bioscience). Inflammatory and
patrolling monocytes were plated in 0.1 ml of complete RPMI-medium
and stimulated as indicated in the figure legends.
For RNA sequencing experiments inflammatory monocytes
(DAPI−veCD45+veCD11b+veNK1.1−veLy6ChighCX3CR1+veCD115+ve), patrolling
monocytes (DAPI−veCD45+veCD11b+veNK1.1−veLy6C−veCX3CR1+veCD115+ve)
and neutrophils (DAPI−veCD45+veCD11b+veNK1.1−veLy6CintermediateGr-1high)
were sorted from spleens of WT and ABIN1[D485N] mice.
RNA sequencing
Total RNA was purified using RNAeasy Micro Kit (QIAGEN) according
to the manufacturer’s instructions and samples analysed on the
Agilent Bioanalyser (#G2939AA; Agilent Technologies) with the RNA
6000 Pico Kit (#5067-1513) to assess the quality and integrity of
the RNA. Libraries were prepared from each RNA sample using the
NEBNext ultra RNA library prep kit for Illumina Inc. (#E7530) with the
NEBNext Poly(A) mRNA magnetic isolation module (#E7490) according
to the protocol provided.
Total-RNA (40 ng) was processed with the Poly(A) mRNA mag-
netic isolation module to capture the mRNA fragments using oligo
d(T) beads which bind to the poly(A) tail of eukaryotic mRNA. After
fragmentation and priming with random hexamers, RNA templates
were removed and a replacement strand synthesised incorporating
dUTP in place of dTTP to generate ds cDNA. AMPure XP beads
(#A63881; Beckman Coulter) were then used to separate the blunt-
ended ds cDNA from the second-strand reaction mix. A single “A”
nucleotide was added to the 39 end of the blunt fragments to
prevent them from ligating to one another during the subsequent
adapter ligation reaction. A single “T” nucleotide at the 39 end of the
adapter provided a complementary overhang for ligation of the
adapter to the fragment. Multiple indexing adapters were then
ligated to the ends of the ds cDNA to prepare them for hybridisation
onto a flow cell. 15 cycles of PCR were then performed to selectively
enrich those DNA fragments that had adapter molecules on both
ends, and to amplify the DNA in the library to the amount required
for sequencing. Libraries were quantified by Qubit using the dsDNA
HS assay, assessed for quality with a DNA HS Kit (#5067-4626; Agilent
Technologies) and sequenced on the NextSeq 550 platform (#SY-
415-1002; Illumina Inc.).
24 samples were divided between two flow cells, with biological
conditions randomized between sequencing runs. Sequencing
resulted in paired-end reads 2 × 75 bp, between 24 and 47 (median
of 31) million reads per sample. The RNA-seq data have been
deposited in ArrayExpress (www.ebi.ac.uk/arrayexpress) under
accession number E-MTAB-8185. RNA-seq reads were mapped to
the reference mouse genome (masked primary assembly GRCm38,
release 93) using STAR 2.6.1a (Dobin et al, 2013). Typically, 80% of
reads were mapped uniquely to the genome. Read counts per gene
were found in the same STAR run, using Ensembl annotations in a
Gene Transfer Format (GTF) file. Differential expression was per-
formed with edgeR 3.26.4 (Robinson et al, 2010; McCarthy et al, 2012)
with three contrasts (three different cell types), for each of the two
genotypes (ABIN1[D485N] versusWT). A Benjamini–Hochbergmultiple-
test correction was applied to test P-values.
Tissue processing for histological evaluation and scoring
Mice were euthanized with CO2. The kidneys, liver, and lungs were
removed and fixed for 48–72 h in 10% neutral buffered formalin.
One kidney was trimmed longitudinally and the contralateral
kidney was trimmed transversally in the mid portion. For the liver,
one sample from the left lobe and two samples from the median
lobe were trimmed. The lungs were processed whole without
trimming. Tissues were processed to paraffin blocks, and 4-μm
sections were stained with haemotoxylin and eosin (H&E) or Pe-
riodic Acid Schiff (kidney only). Kidney, liver, and lung tissue sec-
tions were assessed by a veterinary pathologist (F.M.) blinded to the
genotype of the mice in the different cohorts. Ordinal semi-
quantitative scoring criteria used for the assessment of lesions in
the kidneys, liver, and lungs were defined according to guidelines
and principles of histopathologic scoring in research (Gibson-
Corley et al, 2013) and are detailed below. The photomicrographs
presented in the article were captured using an Olympus BX53 with
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microscope UPlanFL N objective. The ocular lens was WHN10×-H/22
and the camera used was an Olympus SC100. For preparation of the
figures, images were obtained and processed using an Olympus
CellSens Standard and resized using Adobe Photoshop.
Kidney histology
Images of glomeruli were taken with objective 20×/0.50. Glomer-
ulonephritis was defined by a variable combination of changes,
including increased glomerular cellularity, size and lobulation,
mesangial thickening, inflammatory cells in the glomerular tuft/
mesangium, glomerulosclerosis, possible crescent formation, and
possible presence of karyorrhectic debris. Glomerulonephritis was
assessed in 20 glomeruli at 40-fold magnification (objective 40×/
0.75 ocular 10×-H/22) according to a 0–4 ordinal grading scale: 0 =
absent; 1 = mild; 2 = moderate; 3 = marked; 4 = severe.
Liver histology
Images of liver sections were taken with objective 10×/0.30. The
presence of inflammatory cell infiltration with periportal, peri-
vascular, and/or parenchymal distribution was assessed in 20
microscopic fields at 20-fold magnification (objective 20×/0.50
ocular 10×-H/22) with the following 0–4 ordinal grading scale: 0 =
absent; 1 = mild; 2 = moderate; 3 = marked; 4 = severe. Oval cell and/
or bile duct proliferation was also assessed in 20 microscopic fields
at 20-fold magnification with a similar 0–4 grading system. For each
mouse, the average hepatic inflammation and oval cell/bile duct
proliferation scores were calculated. In addition, a cumulative liver
pathology score (defined as the sum of the average hepatic in-
flammation score and oval cell/bile duct proliferation score) was
calculated for each mouse and is presented in the figures.
Lung histology
Images of lung sections were taken with objective 10×/0.30. Lesions
in the lungs, including perivascular/peribronchial inflammatory
infiltrates and presence of inflammatory cells in alveolar septa
were assessed in five microscopic fields at 20-fold magnification
(objective 20×/0.50 ocular 10×-H/22) with the following 0–4 ordinal
grading scale: 0 = absent; 1 = mild; 2 = moderate; 3 = marked; 4 =
severe. An average score was calculated for each endpoint, and a
cumulative lung inflammation score was calculated as the sum of
the average scores of the two endpoints and is presented in the
figures.
Bone marrow chimaera experiment
WT mice expressing CD45.1 (~120 d old) were lethally irradiated
(Nanda et al, 2018) and reconstituted with bone marrow cells (2.5 ×
106 in PBS) via tail vein injection. Following reconstitution, mice
received prophylactic antibiotics in their drinking water. (Levo-
floxacin [Sigma-Aldrich] 0.67 mg/ml for 14 d). Two groups of re-
cipient mice were reconstituted with either CD45.2 WT cells or
CD45.1 WT and CD45.2 ABIN1[D485N] cells, mixed in a 1:1 molar ratio.
The animals were culled 4 mo after irradiation. The spleen was
removed for flow cytometry. Kidneys and liver were collected in
fixative and processed for histological analysis. Serum was ana-
lysed for auto-antibodies.
The IRAK4 inhibitor PF 06426779
The synthesis of PF 06426779 has been described (called compound
20 in Lee et al (2017)). PF 06426779 inhibited IRAK4 in cell-based
assays with an IC50 value of 20 nM and inhibited R848-stimulated
TNF secretion in human andmouse blood with IC50 values of 81 and
158 nM, respectively. The compound inhibited IRAK4 several hun-
dred fold more potently than liver kinase B1, serine threonine ki-
nase16, p53-related protein kinase, nuclear Dbf2-related kinase 1,
and microtubule-associated serine threonine kinase 3, and >1,000-
fold more potently than more than 200 other protein kinases
tested, including the closely related IRAK1.
In vivo administration of the IRAK4 inhibitor
ABIN1[D485N] and WT mice (6–8 wk old) were fed with R&M3 diet
(Research Diets Inc.). Where specified, PF 06426779 was included in
the diet at 4 g/kg food. Blood was collected from the tail vein at
commencement of the study and 5 wk later. Mice were culled 10 wk
later and blood and other tissues were analysed.
Other methods
Cytokine measurements were carried out using Luminex-based
Bio-Plex Mouse Grp 1 Cytokine 23 plex (Bio-Rad Laboratories) or
individual Bio-Plex cytokine kits following the manufacturer’s in-
structions. Autoantibodies to dsDNA and ANA (total Ig; Alpha Di-
agnostics International) were measured by ELISA.
Statistical analysis
Data were analysed using GraphPad Prism 7.05 software. Data in
percentages were transformed in arcsine square root before sta-
tistical analysis. The distribution was determined using the
Shapiro–Wilk normality test. Pair-wise comparison of parametric
and nonparametric data was done using the unpaired t test with
Welch’s correction or unpaired Mann–Whitney test, respectively.
Multiple comparisons of data with normal distribution were per-
formed using one-way ANOVA followed by Tukey’s post hoc test.
Multiple comparison of nonparametric data was done using the
Kruskal–Wallis test, followed by the Mann–Whitney test.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900533.
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